Overview
Toru Fukubayashi practices practicing medicine in Waseda, Japan.
His clinical expertise encompasses Muscle Atrophy, Osteolysis Syndrome Recessive, and Hypermobile Joints.
He is actively involved in clinical research, co-authoring 31 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Toru Fukubayashi
Is Toru Fukubayashi a top-rated expert for Muscle Atrophy?
MediFind is an objective health platform that identifies experts based on real-world data. Toru Fukubayashi is classified as an Experienced expert for Muscle Atrophy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Toru Fukubayashi participate in research or clinical trials?
Yes. Toru Fukubayashi has published 31 articles and abstracts on conditions like Muscle Atrophy. You can view a list of Toru Fukubayashi's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Hypermobile JointsMr. Fukubayashi isExperienced. Learn about Hypermobile Joints.
- Muscle AtrophyMr. Fukubayashi isExperienced. Learn about Muscle Atrophy.
- Osteolysis Syndrome RecessiveMr. Fukubayashi isExperienced. Learn about Osteolysis Syndrome Recessive.